HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Precision BioSciences (NASDAQ:DTIL) and maintained a $60 price target, as stated by analyst Patrick Trucchio.
May 30, 2024 | 11:09 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Precision BioSciences (NASDAQ:DTIL) and maintained a $60 price target, indicating strong confidence in the company's future performance.
The reiteration of a Buy rating and a high price target of $60 by a reputable analyst firm like HC Wainwright & Co. is likely to boost investor confidence in Precision BioSciences, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100